Friday, July 10, 2026

Drug profile · INN

avacincaptad pegol

avacincaptad pegol (IZELVAY) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Sensory organs (S01) S01XA32
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — avacincaptad pegol
Class
Sensory organs (S01)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

avacincaptad pegol (IZELVAY) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN avacincaptad pegol
Brand IZELVAY
Therapeutic class Sensory organs (S01)
ATC code S01XA32

Approval history

Authority Status Date
EMA application withdrawn

Pipeline programs

  1. Avacincaptad pegol, FLUORESCEIN Phase 3 · Astellas Pharma · geographic atrophy
  2. INCA 33989-101 Phase 1 · Incyte · Myeloproliferative Neoplasms

Related & competitor drugs

  1. aflibercept Sensory organs (S01)
  2. atropine sulfate Sensory organs (S01)
  3. bimatoprost Sensory organs (S01)
  4. atropine Sensory organs (S01)
  5. brinzolamide Sensory organs (S01)
  6. latanoprost Sensory organs (S01)

Frequently asked questions

What is avacincaptad pegol?

avacincaptad pegol (IZELVAY) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for avacincaptad pegol?

IZELVAY is a marketed brand name for avacincaptad pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.